This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.Here is a sample of this item:Oncolytics receives $9.1-million from warrant exercise 2009-11-03 09:44 ET - News Release An anonymous director reports ONCOLYTICS BIOTECH(R) INC. ANNOUNCES RESULTS OF SECOND WARRANT EXPIRY DATE ACCELERATION PROGRAM Pursuant to the accelerated expiry of those warrants issued on May 13, 2009, Oncolytics Biotech Inc. has received proceeds of approximately $9.1-million resulting from the exercise of all 3,795,000 warrants. Oncolytics now has 56,662,469 shares issued and outstanding, and cash on hand and available for operations of approximately $23.7-million.
The remainder is available to Stockwatch subscribers. If you would like to give the Stockwatch system a try,
click here for a free 30 day trial subscription. |